Published in Nat Clin Pract Neurol on May 06, 2008
Impact of drug therapy on brachioradial pruritus. An Bras Dermatol (2017) 0.75
A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med (2006) 8.12
painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin (2006) 4.78
NeuPSIG guidelines on neuropathic pain assessment. Pain (2010) 4.04
Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc (2010) 3.92
Pseudoradicular and radicular low-back pain--a disease continuum rather than different entities? Answers from quantitative sensory testing. Pain (2007) 3.91
A new definition of neuropathic pain. Pain (2011) 3.57
Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells. Nat Med (2006) 3.09
Interventional management of neuropathic pain: NeuPSIG recommendations. Pain (2013) 2.75
Drosophila exocyst components Sec5, Sec6, and Sec15 regulate DE-Cadherin trafficking from recycling endosomes to the plasma membrane. Dev Cell (2005) 2.75
The Pharmacological Therapy of Chronic Neuropathic Pain. Dtsch Arztebl Int (2016) 2.45
Is CRPS I a neuropathic pain syndrome? Pain (2006) 2.40
Deconstructing the neuropathic pain phenotype to reveal neural mechanisms. Neuron (2012) 2.11
Using screening tools to identify neuropathic pain. Pain (2006) 2.09
A common variant on chromosome 11q13 is associated with atopic dermatitis. Nat Genet (2009) 1.91
Enhanced expression and secretion of antimicrobial peptides in atopic dermatitis and after superficial skin injury. J Invest Dermatol (2010) 1.89
Considerations for improving assay sensitivity in chronic pain clinical trials: IMMPACT recommendations. Pain (2012) 1.88
Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendations. Pain (2010) 1.84
Clinical features and pathophysiology of complex regional pain syndrome. Lancet Neurol (2011) 1.83
Pain in oxaliplatin-induced neuropathy--sensitisation in the peripheral and central nociceptive system. Eur J Cancer (2007) 1.83
Complex regional pain syndrome: mystery explained? Lancet Neurol (2003) 1.75
Results after balloon angioplasty or stenting of atherosclerotic subclavian artery obstruction. Catheter Cardiovasc Interv (2009) 1.71
Sensory signs in complex regional pain syndrome and peripheral nerve injury. Pain (2011) 1.70
Experimental extracorporeal photopheresis inhibits the sensitization and effector phases of contact hypersensitivity via two mechanisms: generation of IL-10 and induction of regulatory T cells. J Immunol (2008) 1.69
Tissue oxygen reactivity and cerebral autoregulation after severe traumatic brain injury. Crit Care Med (2003) 1.63
Meta-analysis of genome-wide association studies identifies three new risk loci for atopic dermatitis. Nat Genet (2011) 1.60
Value of quantitative sensory testing in neurological and pain disorders: NeuPSIG consensus. Pain (2013) 1.60
Topical menthol--a human model for cold pain by activation and sensitization of C nociceptors. Brain (2004) 1.58
Phototherapy: how does UV work? Photodermatol Photoimmunol Photomed (2005) 1.57
Influence of deep brain stimulation and levodopa on sensory signs in Parkinson's disease. Mov Disord (2010) 1.55
UVR-induced regulatory T cells switch antigen-presenting cells from a stimulatory to a regulatory phenotype. J Invest Dermatol (2010) 1.54
Extremolytes: Natural compounds from extremophiles for versatile applications. Appl Microbiol Biotechnol (2006) 1.52
1,25-dihydroxyvitamin D exerts similar immunosuppressive effects as UVR but is dispensable for local UVR-induced immunosuppression. J Invest Dermatol (2012) 1.50
Intravenous infusion of syngeneic apoptotic cells by photopheresis induces antigen-specific regulatory T cells. J Immunol (2005) 1.49
Drug-coated balloons vs. drug-eluting stents for treatment of long femoropopliteal lesions. J Endovasc Ther (2014) 1.48
Interleukin-12 suppresses ultraviolet radiation-induced apoptosis by inducing DNA repair. Nat Cell Biol (2002) 1.48
Regulatory T cells. J Invest Dermatol (2006) 1.47
Skin barrier function, epidermal proliferation and differentiation in eczema. J Dermatol Sci (2006) 1.47
Who is healthy? Aspects to consider when including healthy volunteers in QST-based studies-a consensus statement by the EUROPAIN and NEUROPAIN consortia. Pain (2015) 1.47
Expression of stem cell markers in human astrocytomas of different WHO grades. J Neurooncol (2007) 1.46
Endovascular treatment of common femoral artery disease: medium-term outcomes of 360 consecutive procedures. J Am Coll Cardiol (2011) 1.46
Treatment of reoccurring instent restenosis following reintervention after stent-supported renal artery angioplasty. Catheter Cardiovasc Interv (2007) 1.46
Systematic review of enriched enrolment, randomised withdrawal trial designs in chronic pain: a new framework for design and reporting. Pain (2015) 1.44
Different underlying pain mechanisms despite identical pain characteristics: a case report of a patient with spinal cord injury. Pain (2012) 1.43
Complex regional pain syndrome-a multifaceted disorder requiring multidimensional care: case study. J Pain (2007) 1.42
Recommendation: daily sun protection in the prevention of chronic UV-induced skin damage. J Dtsch Dermatol Ges (2007) 1.41
The evaluation of neuropathic components in low back pain. Curr Pain Headache Rep (2009) 1.40
Reduced metastasis-suppressor gene mRNA-expression in breast cancer brain metastases. J Cancer Res Clin Oncol (2004) 1.40
Skull metastases: clinical features, differential diagnosis, and review of the literature. Surg Neurol (2003) 1.39
Prevention of UV radiation-induced immunosuppression by IL-12 is dependent on DNA repair. J Exp Med (2005) 1.39
Do we need a third mechanistic descriptor for chronic pain states? Pain (2016) 1.39
Impaired sphingomyelinase activity and epidermal differentiation in atopic dermatitis. J Invest Dermatol (2004) 1.37
Analyses of resected human brain metastases of breast cancer reveal the association between up-regulation of hexokinase 2 and poor prognosis. Mol Cancer Res (2009) 1.36
Translation of symptoms and signs into mechanisms in neuropathic pain. Pain (2003) 1.36
The motor system shows adaptive changes in complex regional pain syndrome. Brain (2007) 1.36
Reference data for quantitative sensory testing (QST): refined stratification for age and a novel method for statistical comparison of group data. Pain (2010) 1.36
Screening of neuropathic pain components in patients with chronic back pain associated with nerve root compression: a prospective observational pilot study (MIPORT). Curr Med Res Opin (2006) 1.34
DNA damage, death receptor activation and reactive oxygen species contribute to ultraviolet radiation-induced apoptosis in an essential and independent way. Oncogene (2002) 1.34
Antiviral and regulatory T cell immunity in a patient with stromal interaction molecule 1 deficiency. J Immunol (2011) 1.32
UV-B radiation induces the expression of antimicrobial peptides in human keratinocytes in vitro and in vivo. J Allergy Clin Immunol (2009) 1.31
Rare and functional SIAE variants are not associated with autoimmune disease risk in up to 66,924 individuals of European ancestry. Nat Genet (2011) 1.30
Evidence and consensus-based German guidelines for the management of analgesia, sedation and delirium in intensive care--short version. Ger Med Sci (2010) 1.30
Long-term management of atopic dermatitis in infants with topical pimecrolimus, a nonsteroid anti-inflammatory drug. J Allergy Clin Immunol (2002) 1.29
Herpes zoster and postherpetic neuralgia: optimizing management in the elderly patient. Drugs Aging (2008) 1.28
Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: a randomized, double-blind, placebo-controlled study. Pain (2003) 1.28
alpha-Melanocyte-stimulating hormone protects from ultraviolet radiation-induced apoptosis and DNA damage. J Biol Chem (2004) 1.26
Sensory symptom profiles and co-morbidities in painful radiculopathy. PLoS One (2011) 1.23
Ultraviolet radiation-induced regulatory T cells not only inhibit the induction but can suppress the effector phase of contact hypersensitivity. J Immunol (2004) 1.22
Independent contribution of three different pathways to ultraviolet-B-induced apoptosis. Biochem Pharmacol (2002) 1.19
Beta2 integrins are required for skin homing of primed T cells but not for priming naive T cells. J Clin Invest (2002) 1.18
Complete compression ultrasonography of the leg veins as a single test for the diagnosis of deep vein thrombosis. Thromb Haemost (2003) 1.18
The antimicrobial protein psoriasin (S100A7) is upregulated in atopic dermatitis and after experimental skin barrier disruption. J Invest Dermatol (2008) 1.18
Schnitzler syndrome: treatment failure to rituximab but response to anakinra. J Am Acad Dermatol (2007) 1.17
A cross-sectional survey of 3035 patients with fibromyalgia: subgroups of patients with typical comorbidities and sensory symptom profiles. Rheumatology (Oxford) (2010) 1.17
In vitro and in vivo P-glycoprotein transport characteristics of rivaroxaban. J Pharmacol Exp Ther (2011) 1.16
Langerhans cells are required for UVR-induced immunosuppression. J Invest Dermatol (2010) 1.16
Postherpetic neuralgia: epidemiology, pathophysiology and management. Expert Rev Neurother (2007) 1.16
Long-term results after directional atherectomy of femoro-popliteal lesions. J Am Coll Cardiol (2006) 1.15
Harlequin syndrome--one face of many etiologies. Nat Clin Pract Neurol (2005) 1.15
Effects of probiotic bacteria and their genomic DNA on TH1/TH2-cytokine production by peripheral blood mononuclear cells (PBMCs) of healthy and allergic subjects. Immunobiology (2008) 1.15
Assessment of neuropathic pain in primary care. Am J Med (2009) 1.14
Clinical efficacy of zanolimumab (HuMax-CD4): two phase 2 studies in refractory cutaneous T-cell lymphoma. Blood (2007) 1.14
Matrix-degrading proteases ADAMTS4 and ADAMTS5 (disintegrins and metalloproteinases with thrombospondin motifs 4 and 5) are expressed in human glioblastomas. Int J Cancer (2006) 1.14
IL-10 controls ultraviolet-induced carcinogenesis in mice. J Immunol (2007) 1.13
Modelling the prevalence and cost of back pain with neuropathic components in the general population. Eur J Pain (2009) 1.12
Complex regional pain syndrome is a disease of the central nervous system. Clin Auton Res (2002) 1.12
Early diagnosis of peripheral nervous system involvement in Fabry disease and treatment of neuropathic pain: the report of an expert panel. BMC Neurol (2011) 1.11
High-density genotyping study identifies four new susceptibility loci for atopic dermatitis. Nat Genet (2013) 1.11
Skin temperature side differences--a diagnostic tool for CRPS? Pain (2002) 1.11
Management of tectal glioma in childhood. Pediatr Neurol (2005) 1.10
Topical 5% lidocaine (lignocaine) medicated plaster treatment for post-herpetic neuralgia: results of a double-blind, placebo-controlled, multinational efficacy and safety trial. Clin Drug Investig (2009) 1.09
CX3CR1 promotes recruitment of human glioma-infiltrating microglia/macrophages (GIMs). Exp Cell Res (2010) 1.09
Molecular mechanisms involved in UV-induced apoptotic cell death. Skin Pharmacol Appl Skin Physiol (2002) 1.08
Safety and efficacy of nonsteroid pimecrolimus cream 1% in the treatment of atopic dermatitis in infants. J Pediatr (2003) 1.08